Search Results - "Zerbi, A"

Refine Results
  1. 1
  2. 2

    Metal-related artifacts in instrumented spine. Techniques for reducing artifacts in CT and MRI: state of the art by Stradiotti, P., Curti, A., Castellazzi, G., Zerbi, A.

    Published in European spine journal (01-06-2009)
    “…The projectional nature of radiogram limits its amount of information about the instrumented spine. MRI and CT imaging can be more helpful, using…”
    Get full text
    Journal Article
  3. 3

    Effect of hospital volume on outcome of pancreaticoduodenectomy in Italy by Balzano, G., Zerbi, A., Capretti, G., Rocchetti, S., Capitanio, V., Di Carlo, V.

    Published in British journal of surgery (01-03-2008)
    “…Background: An inverse relationship between hospital volume and death following pancreatico duodenectomy (PD) has been reported from several countries. The aim…”
    Get full text
    Journal Article
  4. 4

    MULTIFUNCTIONAL 3D MODEL FOR THE FARNESE THEATRE IN PARMA by Zerbi, A., Mikolajewska, S.

    “…Modern surveying technologies allow to obtain a digital copy of cultural assets, which can be more or less adherent to reality. When 3D reconstruction concerns…”
    Get full text
    Journal Article Conference Proceeding
  5. 5

    INTEGRATED PROCESSING OF PHOTOGRAMMETRIC AND LASER SCANNING DATA FOR FRESCOES RESTORATION by Bruno, N., Mikolajewska, S., Roncella, R., Zerbi, A.

    “…The integration of photogrammetry and Terrestrial Laser Scanner (TLS) techniques is often desirable for Cultural Heritage digitization, especially when high…”
    Get full text
    Journal Article Conference Proceeding
  6. 6

    Pancreatic neuroendocrine tumor progression and resistance to everolimus: the crucial role of NF-kB and STAT3 interplay by Vitali, E., Valente, G., Panzardi, A., Laffi, A., Zerbi, A., Uccella, S., Mazziotti, G., Lania, A.

    Published in Journal of endocrinological investigation (01-05-2024)
    “…Purpose The finding of mTOR overactivation in patients affected by pancreatic neuroendocrine tumors (Pa-NETs) led to their treatment with the mTOR inhibitor…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Immune infiltrating cells in duodenal cancers by Donisi, G, Capretti, G, Cortese, N, Rigamonti, A, Gavazzi, F, Nappo, G, Pulvirenti, A, Sollai, M, Spaggiari, P, Zerbi, A, Marchesi, F

    Published in Journal of translational medicine (03-09-2020)
    “…Duodenal adenocarcinoma (DA) is a rare yet aggressive malignancy, with increasing incidence in the last decades. Its low frequency has hampered a thorough…”
    Get full text
    Journal Article
  11. 11

    The impact of SST2 trafficking and signaling in the treatment of pancreatic neuroendocrine tumors by Vitali, E., Piccini, S., Trivellin, G., Smiroldo, V., Lavezzi, E., Zerbi, A., Pepe, G., Lania, A.G.

    Published in Molecular and cellular endocrinology (01-05-2021)
    “…Pancreatic neuroendocrine tumors (Pan-NETs), are heterogeneous neoplasms, whose incidence and prevalence are increasing worldwide. Pan-NETs are characterized…”
    Get full text
    Journal Article
  12. 12

    INTEGRATION OF HISTORICAL GIS DATA IN A HBIM SYSTEM by Bruno, N., Rechichi, F., Achille, C., Zerbi, A., Roncella, R., Fassi, F.

    “…The integration between BIM (Building Information Modeling) and GIS (Geographic Information System) is currently a highly debated research topic. However, the…”
    Get full text
    Journal Article Conference Proceeding
  13. 13

    FROM SURVEY TO MODEL, AND RETURN. THE CASE OF THE PARMA BAPTISTERY by Zerbi, A., Mikolajewska, S.

    “…Although this is not always the common practice, the survey should be an essential preliminary stage to any operation of restoration, enhancement and promotion…”
    Get full text
    Journal Article Conference Proceeding
  14. 14

    Ampullary neuroendocrine neoplasms: surgical experience of a rare and challenging entity by Milanetto, A. C., Pasquali, C., Da Broi, M., Brambilla, T., Capretti, G., Zerbi, A.

    Published in Langenbeck's archives of surgery (01-08-2018)
    “…Purpose Ampullary neuroendocrine neoplasms (NENs) account for < 0.3% of gastrointestinal NENs. Surgical options include transduodenal ampullectomy/tumour…”
    Get full text
    Journal Article
  15. 15
  16. 16

    A novel insight into the anticancer mechanism of metformin in pancreatic neuroendocrine tumor cells by Vitali, E., Boemi, I., Piccini, S., Tarantola, G., Smiroldo, V., Lavezzi, E., Brambilla, T., Zerbi, A., Carnaghi, C., Mantovani, G., Spada, A., Lania, A.G.

    Published in Molecular and cellular endocrinology (01-06-2020)
    “…The antidiabetic drug metformin displays anticancer properties in several neoplasms. In pituitary NETs, aryl hydrocarbon receptor-interacting protein (AIP) is…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Autologous Islet Transplantation in Patients Requiring Pancreatectomy: A Broader Spectrum of Indications Beyond Chronic Pancreatitis by Balzano, G., Maffi, P., Nano, R., Mercalli, A., Melzi, R., Aleotti, F., Zerbi, A., De Cobelli, F., Gavazzi, F., Magistretti, P., Scavini, M., Peccatori, J., Secchi, A., Ciceri, F., Del Maschio, A., Falconi, M., Piemonti, L.

    Published in American journal of transplantation (01-06-2016)
    “…Islet autotransplantation (IAT) is usually performed in patients undergoing pancreatic surgery for chronic pancreatitis. In the present series, IAT was offered…”
    Get full text
    Journal Article
  19. 19

    Pathologic tumor response to neoadjuvant therapy in resected pancreatic cancer: does it affect prognosis? by Donisi, G., Nappo, G., Pacilli, M., Capretti, G. L., Spaggiari, P., Sollai, M., Bozzarelli, S., Zerbi, A.

    Published in Updates in surgery (01-09-2023)
    “…Neoadjuvant therapy (NAT) + surgical resection for pancreatic cancer (PC) has gained consensus in recent years. Pathological response (PR) is generally…”
    Get full text
    Journal Article
  20. 20